14 September 2018

BDA advises Zoetis on the sale of its plant health business in Japan to Nippon Soda

divested plant health business in Japan to

2018

BDA Partners acted as exclusive financial advisor to Zoetis Inc. (www.zoetis.com) on the divestment of its Plant Health business in Japan to Nippon Soda Co., Ltd.  The transaction closed on September 14th.

Deal team

About Nippon Soda

Nippon Soda Co., Ltd. develops, produces, and commercializes chemicals, agrochemicals, and other products in Japan and internationally. Nippon Soda Co., Ltd. was founded in 1920 and is headquartered in Tokyo, Japan. www.nippon-soda.co.jp

About BDA


BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 20 years’ experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Tokyo, Seoul, Shanghai, Hong Kong, Ho Chi Minh City, Singapore and Mumbai. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn our clients’ trust by delivering insightful advice and outstanding outcomes. www.bdapartners.com

BDA formed partnerships with William Blair & Company in 2011 and Development Bank of Japan in 2017.

US securities transactions are performed by BDA Partners’ affiliate, BDA Advisors Inc, a broker-dealer registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc. is a member of the Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorised and regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.

Recent transactions